Reports

Ideas That Generate Results

India being on the ‘threshold of biotech revolution’ has 280 biotech and 180 bio suppliers contributing to the total biotech market worth US $100 billion. The country has a global market worth $91 billion and there is scope for cheap R&D through bio-partnering and co-developing technologies mainly with Chinese and American companies. Already the world pharma companies are seeking India to set their research and development centers here. Moreover, to facilitate foreign investment, capital and government policies are being revised.

It has been found that Indian biotech firms are making a strong position, developing business models and improving product commercialization capabilities. With this, India could make a good $5 billion by 2010.

A new market research report, “Indian Biotech Industry (2005)” by RNCOS provides insights into the Indian biotech industry including product estimates, market segmentation, and regulatory mechanisms, pricing policies, patents and opportunities in international venture ship. The report says how in 2004-05, 20 privately helped drug discovery groups have started to operate in India with their business primarily to create innovations and IPR. The biotech industry is likely to draw huge FDI to the Union Government.

The market research report also details the success of the biotech firms in terms of their business profiles, export outlets, financial performances and future plans. It also has the contact details of the major industry associations.
 
REPORT HIGHLIGHTS 

  - Assessment of what is happening in China across the value chain, the organizational structure and, the interaction between Indo-China biotech businesses and research.
  - Changes in patent policies and Intellectual Property Rights – A strategic analysis.
  - Sales and demand analysis for biotech products in agri-business and clinical studies, 2005-2010.
  - An estimate of the recent and future investment programs in Indian biotechnology sector and growth statistics.
  - SWOT analysis of Indian biotechnology sector.
  - New drafts and policies formulated by National Biotechnology Development Authorities and how it facilitates in private-public partnerships across biotech firms.
  -  Key profiles and marketing strategies.

REPORT FEATURES
 
The market research report “Indian Biotech Industry (2005)” prepared by RNCOS gives a detail analysis of the Indian biotech market scenario, the technological developments and researches. These have been divided into a number of relevant chapters. Chapter 1 giving an introduction is followed by chapter 2 which talks about the changing legal framework of the biotech sector in India mentioning, fiscal incentives, changes in patents acts, plant varieties and Farmers’ Rights Protection Act, 2001 and other regulations for the biotech sector. Chapter 3 gives the state driven initiatives and policies, region wise.
 
Chapter 4 analyzes the Indian biotechnology market for 2005 in terms of size, demand, industry segments, exports, number of companies & associations, employment opportunities, investments and status of biotech parks. Chapter 5 gives the SWOT analysis whereas the chapter 6 discuss about the Indian Biotechnology Industries and outsourcing opportunities. Chapter 7, 8 and 9 talk about R&D strengths, India’s New Draft National Biotechnology Development strategy and the key industry trends and opportunities in biotech industry. Chapter 10 and 11 covers strategies for the industry’s future and financial strategy for emerging bio-companies. Finally, chapter 12 gives the company profiles of key players.